Invention Grant
- Patent Title: Naphthyridine derivatives useful as αvβ6 integrin antagonists
-
Application No.: US14778095Application Date: 2014-03-26
-
Publication No.: US10023568B2Publication Date: 2018-07-17
- Inventor: Niall Andrew Anderson , Brendan John Fallon , John Martin Pritchard
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Jane F. Djung; Kathryn A. Lutomski
- Priority: GB1305668.4 20130328
- International Application: PCT/EP2014/056013 WO 20140326
- International Announcement: WO2014/154725 WO 20141002
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
A compound of formula (I) or a salt thereof wherein R1 represents a hydrogen atom, a methyl group or a ethyl group R2 represents a hydrogen atom or a fluorine atom R3 represents a hydrogen atom, a methyl group or an ethyl group.
Public/Granted literature
- US20160280705A1 NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS Public/Granted day:2016-09-29
Information query
